Bacteriocins of lactic acid bacteria (LAB) are antimicrobial, proteinaceous compounds which typically kill or inhibit growth of closely related bacteria. They were classified into four categories by Klaenhammer (18). Class I and II bacteriocins are the best characterized, and they are distinguished as small, heat-stable peptides. Class I bacteriocins, also termed lantibiotics, undergo extensive posttranslational modification which results in the formation of lanthionine and ␤-methyllanthionine thioether ring structures from the condensation of cysteine with the unusual amino acids dehydroalanine and dehydrobutyrine, respectively. Class II bacteriocins do not undergo posttranslational modification except for cleavage of the leader peptide and, in some cases, formation of disulfide bridges. Class III and IV bacteriocins are the least well characterized and they are distinguished as large, heat-labile proteins and protein complexes containing other chemical moieties, respectively.
Bacteriocins of lactic acid bacteria (LAB) are antimicrobial, proteinaceous compounds which typically kill or inhibit growth of closely related bacteria. They were classified into four categories by Klaenhammer (18) . Class I and II bacteriocins are the best characterized, and they are distinguished as small, heat-stable peptides. Class I bacteriocins, also termed lantibiotics, undergo extensive posttranslational modification which results in the formation of lanthionine and ␤-methyllanthionine thioether ring structures from the condensation of cysteine with the unusual amino acids dehydroalanine and dehydrobutyrine, respectively. Class II bacteriocins do not undergo posttranslational modification except for cleavage of the leader peptide and, in some cases, formation of disulfide bridges. Class III and IV bacteriocins are the least well characterized and they are distinguished as large, heat-labile proteins and protein complexes containing other chemical moieties, respectively.
Well-characterized class II bacteriocins possess an N-terminal extension of typically 18 to 24 amino acids containing a conserved Gly Ϫ2 -Gly Ϫ1 -Xaa ϩ1 processing site (15, 18) . There is a growing family of class II bacteriocins, including carnobacteriocins A (36), B2, BM1 (26, 27) , and leucocin A (13, 31) . Colicin V, produced by many strains of Escherichia coli, is a class II bacteriocin (11, 15) . For some class II bacteriocins (3, 14, 23, 25, 31) and colicin V (10, 11) , it has been shown that export of the bacteriocin from the cell is contingent upon the presence of an ATP-dependent membrane translocator protein, also termed an ATP-binding cassette (ABC) exporter, and an accessory protein whose function in gram-positive-bacterium systems is currently unknown (8) . The genes encoding these proteins are generally located in close proximity to the structural and immunity genes of the bacteriocins. The ABC transporter has also been shown to function as the maturation protease responsible for cleavage of the N-terminal leader peptide at the conserved Gly Ϫ2 -Gly
Ϫ1
-Xaa ϩ1 processing site for lactococcin G (14) and pediocin PA1.0 (33) .
In contrast to bacteriocins and other members of the ABC transporter family, most exported prokaryotic proteins contain an N-terminal signal peptide which is necessary for their export via a common general secretory pathway (the SEC pathway) (for reviews see references 24 and 30). Worobo et al. (37) characterized divergicin A, a strongly hydrophobic, narrowspectrum bacteriocin from Carnobacterium divergens LV13 that is novel in that export of the bacteriocin is not dependent on dedicated secretion machinery. Unprocessed divergicin A contains a leader peptide that does not contain the typical Gly-Gly processing site and does not have homology with the leader sequences of class II bacteriocins; however, it does display characteristics of a prokaryotic signal peptide (37) . Fusion of the signal peptide of divergicin A to alkaline phosphatase resulted in secretion of the enzyme into the periplasmic space in E. coli (37) . Leer et al. (21) characterized acidocin B, a bacteriocin produced by Lactobacillus acidophilus, in which bacteriocin expression also appears to be SEC dependent. Furthermore, export of colicin V into the periplasm of E. coli has been accomplished by fusion of the OmpA signal peptide in front of the mature structural gene for colicin V (38) . Export of colicin V across the outer membrane did not occur.
This study reports the fusion of the signal peptide from divergicin A in place of the leader peptide of carnobacteriocin B2 to allow export of active bacteriocin in the absence of its dedicated secretion machinery. The carnobacteriocin B2 immunity gene was included immediately downstream of the structural gene. Carnobacteriocin B2 was produced in the nonbacteriocinogenic plasmidless variant of the original carnobacteriocin B2 producer strain Carnobacterium piscicola LV17C and by the wild-type strain C. divergens LV13. N-terminal amino acid sequencing of purified carnobacteriocin B2 established that proper processing of the prebacteriocin occurred. Carnobacteriocin B2 produced in C. divergens LV13 demonstrates the first example of multiple-bacteriocin expression via the general secretary pathway.
MATERIALS AND METHODS
Bacterial strains and media. Bacterial strains and plasmids used in this study are listed in Table 1 . Carnobacteria were grown in APT broth (Difco Laboratories, Detroit, Mich.) at 25ЊC without agitation. E. coli was grown in LuriaBertani medium at 37ЊC on a rotary shaker (29) . Agar plates were made by addition of 1.5% (wt/vol) agar to broth media. Antibiotics were added as selective agents when appropriate: erythromycin (200 g ml
Ϫ1
) and ampicillin (100 g ml Ϫ1 ) for E. coli and erythromycin (5 g ml Ϫ1 ) for carnobacteria. Stock cultures of the bacterial strains were stored at Ϫ70ЊC in the appropriate broth containing 20% (vol/vol) glycerol.
Oligonucleotide primer synthesis and amplification reactions. In the 3Ј region of the nucleotide sequence encoding the signal peptide of divergicin A there is a HindIII restriction site located 10 nucleotides upstream of the sequence encoding mature divergicin A (37). A 35-mer oligonucleotide designed to facilitate an in-frame fusion between the signal peptide of divergicin A and the structural gene of carnobacteriocin B2 was synthesized on a DNA synthesizer (Applied Biosystems 391 PCR Mate) for use as a PCR primer (JMc7: 5Ј-CCCAAGCTT CTGCTGTAAATTATGGTAATGGTGTT-3Ј). The first 9 nucleotides of JMc7 regenerate the HindIII restriction endonuclease cleavage site followed by nucleotides encoding the carboxy terminus of the divergicin A signal peptide. The last 21 nucleotides of the primer are complementary to the 5Ј sequence corresponding to the N-terminal sequence of the carnobacteriocin B2 structural gene (cbnB2) immediately after the Gly-Gly cleavage site of the leader peptide. The reverse primer for the PCR amplification (ImmR) was based on the 3Ј nucleotide sequence of the immunity gene for carnobacteriocin B2 (cbiB2) and contains an overhang of 9 nucleotides to accommodate an XbaI restriction endonuclease site (27) . DNA was amplified in a 100-l reaction mixture by using a temperature cycler (OmniGene; InterSciences Inc., Markham, Ontario, Canada). PCR mixtures contained 1.0 M each primer, 200 M deoxynucleoside triphosphates, 5 mM MgCl 2 , 2.5 U of Tli DNA polymerase (Promega), and 1ϫ reaction buffer (Promega). pLQ24 (27) was used as template DNA for the carnobacteriocin B2 reaction. DNA was amplified with 36 cycles (denaturation, 93ЊC, 1 min; annealing, 48ЊC, 1 min; extension, 75ЊC, 2 min) followed by a final extension step at 75ЊC for 5 min.
DNA isolation and manipulation and sequence determination. Isolation of plasmid DNA from E. coli and carnobacteria was done as previously described (29, 36) . Standard methods were used for restriction enzyme digestion, ligations, gel electrophoresis, and E. coli transformation (29) . Transformation of carnobacteria was done as described by Worobo et al. (37) . DNA was sequenced by Taq DyeDeoxy Cycle sequencing (Applied Biosystems model 373A). Sequences were determined bidirectionally in pUC118 by using universal primers.
Production of and immunity to divergicin A and carnobacteriocin B2. Carnobacteria transformed with either pMG36e, pRW19e or pJKM14 were tested for bacteriocin production by using the deferred-antagonism assay (1). Strains containing pMG36e were used as negative controls. The amount of carnobacteriocin B2 produced from strains containing pJKM14 was determined by the spot-on-lawn test (1) at 3-h intervals from a 0.1% inoculum of an overnight culture incubated at 25ЊC. C. divergens LV13 containing pMG36e was used as the indicator organism. Immunity was determined with the transformants as indicators in deferred-inhibition assays. To confirm that the zones of inhibition were caused by a proteinaceous compound, they were inactivated by spotting Pronase E (1 mg ml
; Sigma) prior to overlayering with the sensitive indicator strain. Purification and N-terminal sequencing of carnobacteriocin B2. Partial purification of carnobacteriocin B2 was done with a 1% inoculum of an overnight culture of C. divergens LV13 containing pJKM14 grown in 2 liters of APT broth containing 5 g of erythromycin per ml for 21 h maintained at pH 6.2 with a pH stat (Chem-Cadet; Cole Palmer). The culture was heated (70ЊC, 35 min), and cells were removed by centrifugation. Supernatant was loaded onto an Amberlite XAD-8 column (4 by 40 cm; BDH Chemicals, Poole, England) equilibrated with 0.05% trifluoroacetic acid. The column was washed successively with 3 liters each of 10, 35 and 40% ethanol. C. divergens LV13 containing pJKM14 produces carnobacteriocin B2 and divergicin A; hence, C. divergens LV13 was used as the sensitive indicator strain to eliminate inhibition by divergicin A. The active fraction was eluted with 3 liters of 50% ethanol. This fraction was concentrated by rotary evaporation to approximately 50 ml, and 10 ml was applied to a Sephadex G-50 column (2.5 by 120 cm; Pharmacia) with a running buffer of 0.05% trifluoroacetic acid. Contents of tubes with inhibitory activity were collected, pooled, and concentrated by rotary evaporation to 1 ml. Various amounts of partially purified carnobacteriocin B2 were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and blotted onto polyvinylidene difluoride membrane (Bio-Rad). A duplicate polyacrylamide gel was washed twice with 
RESULTS
Construction of plasmids pRW19e and pJKM14. The bacteriocinogenic plasmids pRW19e and pJKM14 were constructed for use in this study. These plasmids are derivatives of the lactococcal expression vector pMG36e (32) , and transcription of the bacteriocin genes is under control of the P32 promoter. For construction of pRW19e, a 514-bp EcoRV-AccI fragment of pCD3.4 containing both the structural and immunity genes for divergicin A (37) was cloned into the SmaI and AccI sites of pMG36e. When C. piscicola LV17C was transformed with pRW19e the inhibitory spectrum matched that of C. divergens LV13 ( Table 2) . Zones of inhibition could be inactivated by pronase E. C. piscicola LV17C with pRW19e also acquired immunity to divergicin A (Table 2 ). For construction of pJKM14, a 528-bp fragment was amplified by PCR from pLQ24 using the primers JMc7 and ImmR. This fragment was cloned into the HindIII and XbaI sites of pUC118 to create the plasmid pJKM05 and sequenced in both directions to confirm the fidelity of the reaction. No errors were detected (data not shown) in the nucleotide sequence compared with nucleotide sequence of the structural and immunity genes for carnobacteriocin B2 (26) . The 528-bp fragment was excised from pJKM05 with HindIII and KpnI and cloned into these sites in pRW19e, replacing the divergicin A structural and immunity genes (Fig.  1) . The SacI-EcoRI fragment from pJKM14 containing the fusion between the sequence encoding the divergicin A signal peptide and the carnobacteriocin B2 structural gene was cloned into pUC118 and sequenced to confirm that the correct reading frame was maintained (data not shown).
Production of and immunity to divergicin A and carnobacteriocin B2. Bacteriocin production was detected by the deferred-inhibition assay and the spot-on-lawn test against sensitive indicator strains. Results of deferred-inhibition tests are shown in Fig. 2 and Table 2 . C. divergens LV13 is more sensitive to carnobacteriocin B2 than C. piscicola LV17C, as shown by the large inhibitory zone in Fig. 2B . Zones of inhibition for wild-type strains and strains containing pMG36e were identical (data not shown). When C. piscicola LV17C was transformed with pRW19e, divergicin A was produced, as indicated by inhibition of strains sensitive to divergicin A. No activity against C. divergens LV13 was detected. Carnobacteriocin B2 from C. divergens LV13 and C. piscicola LV17C was assayed by the spot-on-lawn technique. In broth, the amounts of carnobacteriocin B2 produced are quite low. Only 100 activity units (AU) ml Ϫ1 were detectable after 21 h of growth from C. piscicola LV17C, and 200 AU ml Ϫ1 were detectable after 24 h of growth from C. divergens LV13. Strains containing pMG36e as controls did not produce inhibitory zones at any time. The wild-type carnobacteriocin B2 producer C. piscicola LV17B produces at least two bacteriocins (26) , making comparisons between the inhibitory spectra of C. piscicola LV17B and C. piscicola LV17C containing pJKM14 difficult. To confirm the identity of the inhibitory substance produced by C. divergens LV13 containing pJKM14, the bacteriocins were purified and the N-terminal amino acid sequence of the probable carnobacteriocin B2 peak was determined and shown to be Val-AsnTyr-Gly-Asn-Gly-Val. This sequence matches the mature sequence of carnobacteriocin B2, indicating that the inhibitory substance was in fact carnobacteriocin B2 and that proper processing of the bacteriocin occurred beyond the Ala-Ser-Ala processing site of the divergicin A signal peptide (Fig. 1) . Production of carnobacteriocin B2 from pJKM14 was also accomplished in the meat isolates C. piscicola UAL26 and C. divergens UAL278 and in Lactococcus lactis IL1403 (data not shown).
DISCUSSION
The recent explosion of research on bacteriocins from LAB and other gram-positive bacteria resulted in the characterization of two novel bacteriocins, divergicin A and acidocin B, that appear to rely on the general protein secretion pathway in bacteria rather than the dedicated export systems of bacteriocins (21, 37) . Acidocin B produced by Lactobacillus acidophilus has a relatively broad spectrum of activity and could have an important role in food safety; however, divergicin A produced by C. divergens does not inhibit organisms of practical importance. Antimicrobial activity of divergicin A has been demonstrated only against other species of Carnobacterium (37) . Carnobacteriocin B2 is a relatively broad-spectrum bacteriocin with activity against many LAB, strains of Listeria monocytogenes, and some strains of Enterococcus spp. Our research goals include the development of LAB which produce multiple, broad-spectrum bacteriocins with different spectra of activity to encompass a broad range of antimicrobial activity. Using a general secretion pathway rather than a dedicated export system offers the advantage of a substantial decrease in the amount of genetic information required for independent bacteriocin expression. In the case of carnobacteriocin B2, approximately 9.5 kb of DNA is required (25) . In this study we have reduced the amount of DNA required for expression of carnobacteriocin B2 to approximately 600 bp, not including a promoter.
Export systems for class II bacteriocins typically contain two proteins, an ABC exporter and an accessory protein of unknown function (8) . The ability of carnobacteriocin B2 to be secreted via the SEC pathway was originally questioned, partly because of the unknown function of the accessory protein. In gram-negative-bacterium systems, the accessory protein is postulated to facilitate export of compounds through both the inner and outer membranes (7). Zhang et al. (38) showed that although colicin V can be secreted across the cytoplasmic membrane via a SEC-dependent pathway, secretion into the external medium is not achieved. The colicin V dedicated secretion system is therefore necessary for export across both membranes. This function of the accessory protein is not required for export of proteins from gram-positive cells. It is unlikely that this protein modifies the bacteriocin because carnobacteriocin B2 does not undergo posttranslational modification (26) . For the export of bacteriocins in gram-positive bacteria, the accessory protein must either facilitate export of the bacteriocin across the cytoplasmic membrane in conjunction with the ABC exporter protein or aid in processing of the leader peptide, or both. This study confirms that the accessory protein is not required for production of active bacteriocin, so it must be involved in export, leader peptide recognition, and/or processing. Also, it was not known whether the natural leader peptide of carnobacteriocin B2 was required to maintain the bacteriocin in an inactive state and whether replacing it with the signal peptide of divergicin A would have a toxic effect on the producer organism. If this is the case, the divergicin A signal peptide may also function to maintain the bacteriocin in an inactive conformation.
The typical leader sequences of class II bacteriocins have a large amount of homology (15) , and it may be possible to produce multiple bacteriocins with dedicated secretion machinery of a single bacteriocin. There is evidence that some class II bacteriocins can access dedicated secretion machinery from heterologous bacteriocins. Allison et al. (2) reported that both peptides of the two-component lactacin F utilize the bacteriocin secretion machinery of C. piscicola LV17. The N-terminal leader peptides of the carnobacteriocins and the lactacin F peptides have the highest similarity of class II bacteriocins, but it is not known if bacteriocins with less similarity in their leaders could access the export machinery of C. piscicola LV17 or the secretion machinery of other bacteriocins. Some reports suggest that one set of export machinery may not function adequately to export heterologous peptides. When the leader peptide of the lantibiotic nisin Z was replaced with that of the homologous lantibiotic subtilin, the subtilin leader peptide directed biosynthesis and export of pronisin Z but it was not cleaved, resulting in at least 200-fold-lower antimicrobial activity (19) . Van Belkum and Stiles (31) showed that lactococcin A utilizes the secretion system for leucocin A to a limited extent, while mutants in the leucocin A secretion machinery could not be complemented with lactococcin A secretion apparatus.
It is not clear why bacteriocins have a dedicated export system when it appears from this study that with an appropriate signal peptide they can access the general SEC-dependent pathway of the cell. SEC-dependent secretion requires a protein that contains an N-terminal signal sequence with three distinct characteristics, including a positively charged amino terminus, a hydrophobic core, and a cleavage region (16) . The posttranslationally modified class I bacteriocins may be unable to cross the cytoplasmic membrane via the SEC pathway because the lanthionine ring structures could maintain the peptide in a secretion-incompetent conformation. This should not apply to class II bacteriocins. There are some features of proteins which inhibit their secretion by the SEC pathway (20, 22, 35) . A net positive charge at the N terminus of a protein may interfere with export because of interactions with the negatively charged phospholipids in the cell membrane or the effect of the positively charged membrane potential (5). However, there is evidence that this restraint is not as important in gram-positive bacteria as it is in gram-negative bacteria. Borchert and Nagarajan (4) showed that a wide variety of amino acids are tolerated at the ϩ1 position in the SECdependent secretion of levansucrase from Bacillus amyloliquefaciens. Furthermore, leucocin A contains a lysine residue at the mature N terminus and export is still accomplished (unpublished data). Plantaracin C from Lactobacillus plantarum has lysine residues as four of the first five amino acids (12) . It would be interesting to determine if multiple positive charges at the N termini of these bacteriocins will interfere with export via the divergicin A signal peptide secretion system. There may also be other sequences located within larger proteins which may inhibit export, but it has not been determined if this is simply due to features of protein folding (20, 28) . Molecular folding of the small class II bacteriocins would not likely inhibit export, but it could affect the larger heat-labile class III bacteriocins, such as the chromosomally encoded, hydrophilic bacteriocin helveticin J (9, 17) .
Bacteriocins may utilize the dedicated export pathway because it may be more efficient for the cell; however, comparison between these two systems would be very difficult. As shown here, under control of the P32 promoter in the plasmid pMG36e, export of carnobacteriocin B2 by the general protein secretion pathway appears to be less efficient in comparison with production from the wild-type organism. Production from C. piscicola LV17B reached a maximum of 400 AU/ml (26) . C. piscicola LV17B produces at least two separate bacteriocins from one set of secretion machinery which appears to be under the control of a complex regulation system (25) . For comparison, the bacteriocin export cluster and the signal peptide dependent system should be expressed from the same expression vector to control for the copy number of these genes, and transcription should be under control of the same promoter. However, this would not take into account the amounts of the dedicated secretion proteins relative to the amounts of the SEC pathway proteins.
The signal peptide of divergicin A functions in a variety of hosts because carnobacteriocin B2 was also produced in the meat isolates C. piscicola UAL26 and C. divergens UAL278 and in Lactococcus lactis IL1403 (data not shown). Divergicin A is also produced by E. coli (37) . Our goal is to use bacteriocinproducing LAB to inhibit pathogenic and spoilage organisms in meats and to use combinations of bacteriocins to enhance the overall effectiveness against target organisms. Using this system for bacteriocin export, we plan to express various bacteriocins that have different spectra of activity and possibly different modes of action from a single organism. Specific strains of LAB will be chosen for use as hosts for this vector on the basis of their characteristics relevant to certain food systems.
